Illumina Inc (ILMN)
$116.69
1.60 (1.35%)
ILMN Stock Quote Delayed 30 Minutes
Why Is Illumina (ILMN) Stock Plunging 10% Today?
California-based gene sequencer Illumina is well in the red today after a brutal earnings miss. ILMN stock is down 10% on weak results.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
17.12B
PE Ratio
-15.90
EPS
-7.34
Volume (Avg. Vol.)
1.81M
Day's Range
$115.73 - $119.18
52-Week Range
$89.00 - $232.23
Dividend & Yield
N/A (N/A)
ILMN Stock Predictions, Articles, and Illumina Inc News
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.
Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved
Illumina will likely be allowed to buy Grail. But even without that deal, ILMN stock is very attractive, given the company's strong growth drivers.
Illumina News: ILMN Stock Slides Lower on $8 Billion Grail Deal
Illumina's news of its $8 billion deal to acquire Grail, a healthcare company focused on cancer detection, has ILMN stock down on Monday.
Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook
Illumina (ILMN) news for Monday includes ILMN stock falling on a weak outlook for 2020, as well as some other news about a deal.
Investors Should Wait for Sky-High Valuations on Illumina Stock to Deflate
You pay a high price for a company with near monopoly like Illumina. ILMN stock has 70% market share, but Its valuation is too high.
VIDEO: Biotech Stocks and the Future of Healthcare
Tune in to 'Moneyline' to learn more about new opportunities in biotech stocks and how else to invest in the future of healthcare.
4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB
Square, Johnson & Johnson, Illumina, Canopy Growth and Aurora Cannabis are our top stock trades for Monday.
Illumina News: Why ILMN Stock Is Plummeting
Illumina news for Friday concerning early results for the second quarter of 2019 that are below estimates is hitting ILMN stock hard.
Nasdaq Today: Apple Loses Ive and the Nasdaq’s Q3 Outlook
The second quarter is the books, at least as far as the stock market is concerned. Here's a look at the Nasdaq today.
